Sponsored Webinar: The Role of Enhanced Pathogen Detection in the Management of Septic Pneumonia Patients
Sponsored by bioMérieux
The clinical use of multiplex PCR platforms, like the Biofire® Filmarray® Pneumonia (PN) in CAP patients dramatically increases the frequency of detection of potential viral and bacterial pathogens. The companion use of biomarkers, like VIDAS® B•R•A•H•M•S™ PCT™ to measure serum procalcitonin levels helps adjudicate whether the detected potential pathogens are colonizing or invading. The combination of enhanced pathogen detection and PCT levels is of great help in antibiotic stewardship activities.
This course was originally recorded on 3/30/2020.
Nurses, physicians, pharmacists, emergency responders, healthcare management teams, and other healthcare staff may benefit.
At the end of the presentation, the attendee should be able to:
- Restate the results of recent controlled clinical trial data that documents the sensitivity of the Biofire Filmarray multiplex PCR panel in the detection of potential viral and bacterial pathogens in septic patients with Community-acquired pneumonia.
- Identify the important variables that influence serum procalcitonin levels.
- State how to use serum procalcitonin levels to help determine the significance of detected viral and /or bacterial pathogens.
Sepsis Alliance gratefully acknowledges the support provided for this sponsor innovation webinar by bioMérieux.
David N. Gilbert, MD, MACP
Chief of Infectious Diseases, Providence Portland Medical Center; Professor of Medicine, Oregon Health Sciences University
Dr. Gilbert did his infectious diseases fellowship training with Jay P. Sanford, MD, at the University of Texas Southwestern Medical School in Dallas, Texas. Dr. Gilbert is Chief of Infectious Diseases at Providence Portland Medical Center in Portland, Oregon. He is also Professor of Medicine at Oregon Health Sciences University. In the 1970s, he was on the editorial board of the Sanford Guide where his association extends back to its early editions. He was IDSA President in 2002. Dr. Gilbert’s interest is all facets of infectious disease with an emphasis on antimicrobials. His current project is the role of rapid molecular diagnostics in antimicrobial stewardship.
No continuing education credits are offered for this sponsored webinar.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.